Emerrx Biopharma is a preclinical-stage startup developing next-generation intranasal drug delivery technologies. Our lead program is a breakthrough intranasal naloxone with an IV-like pharmacokinetic profile, designed to address the opioid overdose crisis with faster and more effective rescue. Built on a proprietary platform, our approach has broad potential for other emergency and CNS drug applications.
Company Details
- Founded
- 2025
- Address
- 1000 Atlantic Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.emerrx.com
- Keywords
- Woody Creek Capital Partners.
- HQ
- Alameda, CA
Emerrx Biopharma Questions
Emerrx Biopharma's website is http://www.emerrx.com
Emerrx Biopharma's LinkedIn profile is https://www.linkedin.com/company/emerrx-biopharma
Emerrx Biopharma's industry is
Biotechnology Research
Emerrx Biopharma's top competitors are
Government Of Belize,
Gratus Solutions,
Ractigen Therapeutics,
N1 Life,
Bryologyx,
Friends Of The Forest Preserve District Of Dupage County,
Airrived,
Woody Creek Capital Partners,
Streame.com,
Lobo Cannagar.
Emerrx Biopharma's categories are Biotechnology Research
Emerrx Biopharma's founding year is 2025
